Continuous glucose monitoring as a close to real life alternative to meal studies - a pilot study with a functional drink containing amino acids and chromium.

Front Med Technol · 2022 · PMC9433800 · PMID 36062264

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

borderline significantp = 0.053so close (0.05 < p ≤ 0.1)

The 14% difference in C-max between placebo and FDJ was significant ( p = 0.001), whereas the 6% difference between placebo and FD was borderline significant ( p = 0.053).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.